Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Questcor Pharmaceuticals Inc (QCOR)    
$76.95 1.51 (1.92%) as of 4:30 Thu 4/17


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 63,490,000 as of 6/30
Market Cap: 4.89(B)
Last Volume: 2,178,681 Avg Vol: 2,114,211
52 Week Range: $27.9 - $85.16
Level I Sector: Industrials
Level II Sector:   Diversified Services
Level III Sector:      Rental & Leasing Services

Member Indexes:

    AMEX COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Questcor Pharmaceuticals is a biopharmaceutical company focused on the treatment of patients with autoimmune and inflammatory disorders. Co.'s primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of 19 indications, including the treatment of exacerbations of multiple sclerosis in adults, as monotherapy for the treatment of infantile spasms in infants and children, and for several rheumatology related conditions. Co.'s other product is Doral® (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 3,250 69,250
Total Buy Value $0 $0 $149,986 $1,747,082
Total People Bought 0 0 1 4
Total Buy Transactions 0 0 1 5
Total Shares Sold 1,072,791 1,882,791 2,717,245 3,214,475
Total Sell Value $79,610,774 $129,406,164 $171,558,603 $192,635,311
Total People Sold 7 7 8 9
Total Sell Transactions 40 52 74 88
End Date 2014-01-19 2013-10-18 2013-04-19 2012-04-19

   
Records found: 396
  Page 1 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bailey Don M President and CEO   •       •      –    2014-04-14 4 OE $5.12 $204,800 I/I 40,000 139,000     -
   Bailey Don M President and CEO   •       •      –    2014-04-14 4 S $78.17 $3,186,189 I/I (40,000) 99,000 2%     
   Mulroy Michael H. See Remarks   •       –      –    2014-04-10 4 S $85.03 $850,400 D/D (10,000) 77,063 6%     
   Mulroy Michael H. See Remarks   •       –      –    2014-04-10 4 OE $14.24 $142,400 D/D 10,000 87,063     -
   Bradsher Neal C Director   –       •      –    2014-04-07 4 AS $0.00 $0 I/I (0) 2,046,660 -5%     
   Farrell Stephen C Director   –       •      –    2014-04-07 4 OE $4.75 $35,625 D/D 7,500 27,933     -
   Farrell Stephen C Director   –       •      –    2014-04-07 4 S $84.57 $634,275 D/D (7,500) 20,433 5%     
   Bradsher Neal C Director   –       •      –    2014-04-07 4 AS $83.96 $17,212,087 D/D (205,000) 2,046,660 -5%     
   Silverman Lou Director   –       •      –    2014-04-07 4 OE $4.08 $40,800 D/D 10,000 24,183     -
   Silverman Lou Director   –       •      –    2014-04-07 4 S $84.57 $845,700 D/D (10,000) 14,183 5%     
   Farrell Stephen C Director   –       •      –    2014-04-03 4 S $72.00 $180,000 D/D (2,500) 20,433 -7%     
   Farrell Stephen C Director   –       •      –    2014-04-03 4 OE $4.75 $11,875 D/D 2,500 22,933     -
   Medeiros David Jeffrey EVP and CTO   •       –      –    2014-03-17 4 S $62.36 $143,429 D/D (2,291) 120,039 -25%     
   Medeiros David Jeffrey EVP and CTO   •       –      –    2014-03-17 4 OE $14.24 $59,549 D/D 2,291 122,330     -
   Young David Chief Scientific Officer   •       –      –    2014-03-14 4 S $61.78 $373,669 D/D (6,000) 111,741 -22%     
   Young David Chief Scientific Officer   •       –      –    2014-03-14 4 OE $4.54 $27,240 D/D 6,000 117,741     -
   Bailey Don M President and CEO   •       •      –    2014-03-13 4 OE $5.12 $204,800 I/I 40,000 139,000     -
   Bailey Don M President and CEO   •       •      –    2014-03-13 4 S $61.67 $2,508,292 I/I (40,000) 99,000 -25%     
   Mulroy Michael H. See Remarks   •       –      –    2014-03-10 4 S $63.91 $647,991 D/D (10,000) 77,063 -19%     
   Mulroy Michael H. See Remarks   •       –      –    2014-03-10 4 OE $14.24 $142,400 D/D 10,000 87,063     -
   Farrell Stephen C Director   –       •      –    2014-03-07 4 S $65.21 $326,064 D/D (5,000) 15,433 -17%     
   Young David Chief Scientific Officer   •       –      –    2014-03-03 4 OE $5.77 $34,620 D/D 6,000 111,741     -
   Medeiros David Jeffrey EVP and CTO   •       –      –    2014-03-03 4 S $62.00 $51,708 D/D (834) 120,039 -22%     
   Medeiros David Jeffrey EVP and CTO   •       –      –    2014-03-03 4 OE $35.78 $29,841 D/D 834 120,873     -
   Bradsher Neal C Director   –       •      –    2014-02-25 4 AS $0.00 $0 I/I (0) 2,251,660 4%     

  396 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed